Baxter Expands Pharmaceuticals Portfolio With Five Injectable Products In U.S.
Baxter Expands Pharmaceuticals Portfolio With Five Injectable Products In U.S.
百特在美國推出五種注射產品,擴大藥品產品組合
- Five new launches reinforce Baxter's focus on differentiated products and enhance the company's Pharmaceuticals portfolio in critical therapeutic areas
- Products feature ready-to-use formulations to help support patient safety and offer added convenience for healthcare professionals
- 五項新上市強化了百特對差異化產品的關注,並增強了該公司在關鍵治療領域的藥品組合
- 產品採用即用型配方,有助於支持患者安全,爲醫療保健專業人員提供更多便利
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。